If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Deborah Toppmeyer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
9-aminocamptothecin Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 3130 Citations
  • 22 h-Index
  • 46 Article
  • 8 Review article
  • 1 Editorial
  • 1 Letter

5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost

Gupta, A., Yegya-Raman, N., Sayan, M., Ahlawat, S., Ohri, N., Goyal, S., Moore, D., Eladoumikdachi, F., Toppmeyer, D. & Haffty, B., Oct 1 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 2, p. 267-274 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

acceleration (physics)
breast
radiation therapy
Breast
Radiotherapy
3 Citations (Scopus)

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

Rashkin, S. R., Chua, K. C., Ho, C., Mulkey, F., Jiang, C., Mushiroda, T., Kubo, M., Friedman, P. N., Rugo, H. S., McLeod, H. L., Ratain, M. J., Castillos, F., Naughton, M., Overmoyer, B., Toppmeyer, D., Witte, J. S., Owzar, K. & Kroetz, D. L., Mar 1 2019, In : Clinical pharmacology and therapeutics. 105, 3, p. 738-745 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Pharmacogenetics
Disease-Free Survival
Area Under Curve
Genome
Breast Neoplasms

Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer

Sparano, J. A., Gray, R. J., Ravdin, P. M., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., Badve, S. S., Saphner, T. J., Wagner, L. I., Whelan, T. J., Ellis, M. J., Paik, S., Wood, W. C., Keane, M. M. & 10 others, Gomez Moreno, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Brufsky, A. M., Toppmeyer, D. L., Kaklamani, V. G., Berenberg, J. L., Abrams, J. & Sledge, G. W., Jun 20 2019, In : New England Journal of Medicine. 380, 25, p. 2395-2405 11 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Recurrence
Therapeutics
Drug Therapy
Confidence Intervals

Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy

Manne, S., Smith, B., Mitarotondo, A., Frederick, S., Toppmeyer, D. & Kirstein, L., May 1 2019, In : Patient Education and Counseling. 102, 5, p. 902-908 7 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Breast Neoplasms
Self Efficacy
Motivation
Neoplasms
Foster Home Care
24 Citations (Scopus)

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study

Adams, S., Schmid, P., Rugo, H. S., Winer, E. P., Loirat, D., Awada, A., Cescon, D. W., Iwata, H., Campone, M., Nanda, R., Hui, R., Curigliano, G., Toppmeyer, D., O'Shaughnessy, J., Loi, S., Paluch-Shimon, S., Tan, A. R., Card, D., Zhao, J., Karantza, V. & 1 others, Cortés, J., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 397-404 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Therapeutics
Population
Safety
pembrolizumab